News
BiomX has published promising phase 1b/2a trial results in Nature Communications, demonstrating that its phage cocktail BX004 ...
The Emmy nominee also created Sherri Shepherd's sitcom and worked on 'Ellen,' 'The PJs,' 'Boardwalk Empire' and more.
The deal gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication Ohtuvayre.
Vertex Pharmaceuticals’ cystic fibrosis (CF) therapy Alyftrek (deutivacaftor/tezacaftor/vanzacaftor) has been approved by the European Commission (EC).
Vertex Pharmaceuticals Incorporated remains a top Buy with a strong cystic fibrosis franchise, innovative pipeline, and cell therapies. Click for my VRTX update.
3h
The Marion Star on MSNCommunity members sweep streets, raise brooms in memory of friend to all, Kenny SpaffordKenneth "Kenny" M. Spafford was remember fondly by community members as then lined the street in his memory on Wednesday, ...
Merck ( NYSE: MRK) has confirmed a deal worth around $10 billion to acquire Verona Pharma ( NASDAQ: VRNA ), a biotech firm ...
The New Jersey-based pharma has inked one of the biggest deals of the year in pursuit of a promising new way to treat COPD.
The genetic disorder cystic fibrosis is unique because it can cause both breathing and digestive problems. Some 40,000 people ...
I’ve been living on borrowed time since my double lung transplant surgery seven years ago,” said Kelly Asbell, 47, of Valparaiso. “...I want to live longer to watch my kids graduate next year. God ...
Hosted on MSN17h
The debilitating impact of cystic fibrosisMicrosoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and ...
Panelists discuss that improving outcomes for patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) requires multifaceted efforts including developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results